onbody

<!-- Name:DistributionId Value:8744316 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4577 -->…

New York, Jan. 21, 2022 (GLOBE NEWSWIRE) -- According to our new research study on “Wearable Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type (On-Body Injectors and Off-Body Injectors); Application…

- UDENYCA® On-Body Injector (OBI) Achieved Both Pharmacokinetic and Pharmacodynamic Bioequivalence in Randomized Clinical Trial - Coherus plans to seek U.S. marketing authorization for the UDENYCA® OBI in 2022 REDWOOD CITY, Calif., Oct.…

London, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “On-body Drug Delivery Devices - Intellectual Property Landscape: Focus on Popular / Relevant Prior Art Search Expressions, Patent Valuation,…